Abstract
In this study, we report plasma hepatocyte growth factor (HGF) levels during cancer chemotherapy and the relationship between plasma HGF and pneumonia onset in 19 patients with primary lung cancer. These measurements are compared with patients plasma HGF levels prior to cancer chemotherapy, as well as with plasma HGF levels in 23 control patients with silicosis. Plasma HGF, as well as peripheral white blood cells and C-reactive protein, were measured every three days during cancer chemotherapy. In the eight patients who did not develop pneumonia, plasma HGF remained within normal limits. In the 11 patients who did develop pneumonia, however, HGF exceeded normal limits three days after the onset of infection. Further-more, the maximum HGF concentration was significantly higher in the 11 patients with pneumonia (0.62±0.12 ng/mL) than in the eight without complications (0.24±0.02,P<0.01), in the entire lung cancer group prior to chemotherapy (0.17±0.01,P<0.01), or in the 23 control patients with silicosis (0.22±0.01,P<0.01). This suggests that HGF may play a role in repairing lung damage due to pneumonia.
Similar content being viewed by others
References
Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450–1459.
Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990;4:176–187.
Gherardi E, Stoker M. Hepatocyte growth factor-scatter factor: mitogen, motogen, and met. Cancer Cells 1991;3:227–232.
Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncol 1992;3:27–54.
Weidner KM, Hartmann G, Sachs M, Birchmeier W. Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-met. Am J Respir Cell Mol Biol 1993;8:229–237.
Yanagita K, Matsumoto Y, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993;268:21212–21217.
Mason RJ, Leslie CC, McCormick-Shannon K, Deterding RR, Nakamura T, Rubin JS, Shannon JM. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am J Respir Cell Mol Biol 1994;11:561–567.
Wilson WR, Gilbert DN, Bisno AL, Freedman LR, Smith C, Drusano G, Kaye D. General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin Infect Dis 1992;15(suppl 1):S62-S88.
Horie S, Higashihara E, Nutahara K, Mikami Y, Okubo A, Kano M, Kawabe K. Mediation of renal cyst formation by hepatocyte growth factor. Lancet 1994;344:789–791.
Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor. Biochem Biophys Res Commun 1992;182:802–809.
Author information
Authors and Affiliations
About this article
Cite this article
Hojo, S., Fujita, J., Yamadori, I. et al. Serial measurements of plasma hepatocyte growth factor in patients with pneumonia following cancer chemotherapy. J Infect Chemother 2, 49–51 (1996). https://doi.org/10.1007/BF02355198
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02355198